Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.54% |
$114,712
$91.77 p/Share
|
Dec 28
2020 |
|
AKTS
|
Suzanne B Rudy |
SELL
Open market or private sale
|
Direct | 927 Reduced 0.96% |
$11,801
$12.73 p/Share
|
Dec 28
2020 |
|
IMMR
|
William C Martin
Chief Strategy Officer |
SELL
Open market or private sale
|
Indirect | 1,093,710 Reduced 28.94% |
$10,587,113
$9.68 p/Share
|
Dec 28
2020 |
|
KVHI
|
Robert J Balog
COO |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$1,154
$11.54 p/Share
|
Dec 28
2020 |
|
MLSS
|
Joseph D'Agostino
CFO & COO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.81% |
$39,400
$1.97 p/Share
|
Dec 28
2020 |
|
EQ
|
Stephen Connelly
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 2.46% |
$113,000
$4.52 p/Share
|
Dec 28
2020 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$22,400
$1.12 p/Share
|
Dec 28
2020 |
|
GLYC
|
Rachel K. King |
SELL
Open market or private sale
|
Direct | 84,176 Reduced 19.12% |
$329,128
$3.91 p/Share
|
Dec 28
2020 |
|
CYCN
|
Mark G Currie
President and CSO |
SELL
Open market or private sale
|
Direct | 20,107 Reduced 7.4% |
$60,522
$3.01 p/Share
|
Dec 28
2020 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 465 Reduced 100.0% |
$10,142
$21.81 p/Share
|
Dec 28
2020 |
|
AWX
|
Bryan Saksa
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 100.0% |
$108,000
$4.5 p/Share
|
Dec 28
2020 |
|
LOVE
|
Albert Jack Krause
Director |
SELL
Open market or private sale
|
Direct | 6,816 Reduced 5.44% |
$283,886
$41.65 p/Share
|
Dec 28
2020 |
|
PLAN
|
Sandesh Kaveripatnam
Director |
SELL
Open market or private sale
|
Direct | 2,184 Reduced 2.79% |
$164,477
$75.31 p/Share
|
Dec 28
2020 |
|
CSLT
|
Seth B. Cohen
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 7.45% |
$45,000
$1.5 p/Share
|
Dec 28
2020 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 0.16% |
$23,200
$0.29 p/Share
|
Dec 28
2020 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.01% |
$11,100
$22.2 p/Share
|
Dec 28
2020 |
|
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 29,518 Reduced 100.0% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Indirect | 29,518 Reduced 38.77% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 29,518 Reduced 38.77% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
CURO
|
Donald Gayhardt
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.9% |
$213,450
$14.23 p/Share
|
Dec 28
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
BUY
Open market or private sale
|
Indirect | 7,000 Added 0.03% |
$1,610
$0.23 p/Share
|
Dec 28
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 410 Reduced 0.0% |
$98
$0.24 p/Share
|
Dec 28
2020 |
|
CIDM
|
Peixin Xu
Director |
SELL
Open market or private sale
|
Indirect | 1,831,918 Reduced 4.48% |
$1,154,108
$0.63 p/Share
|
Dec 28
2020 |
|
CCB
|
Eric M Sprink
CEO |
SELL
Open market or private sale
|
Indirect | 4,691 Reduced 100.0% |
$101,373
$21.61 p/Share
|
Dec 28
2020 |
|
RTSL
|
Donal Ray Schmidt Jr.
CEO |
SELL
Open market or private sale
|
Indirect | 3,666,667 Reduced 3.42% |
$1,026,667
$0.28 p/Share
|
Dec 28
2020 |
|
RTSL
|
Sean Paul Berrier
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 600,000 Reduced 1.18% |
$150,000
$0.25 p/Share
|
Dec 28
2020 |
|
APRE
|
Redmile Group, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 500,000 Reduced 11.06% |
$2,845,000
$5.69 p/Share
|
Dec 28
2020 |
|
STOK
|
Gene Liau
EVP Research & Preclinical Dev |
SELL
Open market or private sale
|
Direct | 149 Reduced 0.69% |
$8,751
$58.73 p/Share
|
Dec 28
2020 |
|
OHI
|
Robert O Stephenson
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 400 Reduced 0.18% |
$14,900
$37.25 p/Share
|
Dec 24
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.04% |
$2,300
$0.23 p/Share
|
Dec 24
2020 |
|
RGT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,866 Reduced 1.19% |
$230,558
$13.67 p/Share
|
Dec 24
2020 |
|
AMC
|
Mudrick Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 1.93% |
$630,000
$2.52 p/Share
|
Dec 24
2020 |
|
PINS
|
Benjamin Silbermann
Director |
SELL
Open market or private sale
|
Direct | 105,000 Reduced 100.0% |
$7,537,950
$71.79 p/Share
|
Dec 24
2020 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 77,914 Reduced 60.63% |
$8,622,742
$110.67 p/Share
|
Dec 24
2020 |
|
SITC
|
Alexander Otto |
SELL
Open market or private sale
|
Direct | 25,410 Reduced 0.08% |
$259,436
$10.21 p/Share
|
Dec 24
2020 |
|
RPTX
|
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 432 Reduced 0.5% |
$14,316
$33.14 p/Share
|
Dec 24
2020 |
|
IMMR
|
William C Martin
Chief Strategy Officer |
SELL
Open market or private sale
|
Indirect | 3,134 Reduced 0.08% |
$28,206
$9.0 p/Share
|
Dec 24
2020 |
|
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.29% |
$627,950
$125.59 p/Share
|
Dec 24
2020 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,260,000
$126.0 p/Share
|
Dec 24
2020 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 8,401 Reduced 0.13% |
$185,242
$22.05 p/Share
|
Dec 24
2020 |
|
SOL
|
Shah Capital Management
CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 836,211 Reduced 6.54% |
$8,403,921
$10.05 p/Share
|
Dec 24
2020 |
|
HNNA
|
Rodger Offenbach |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 1.25% |
$13,230
$8.82 p/Share
|
Dec 24
2020 |
|
RPLA
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 75,600 Reduced 0.93% |
$802,116
$10.61 p/Share
|
Dec 24
2020 |
|
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 7,700 Reduced 0.08% |
$467,390
$60.7 p/Share
|
Dec 24
2020 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 8,266 Reduced 0.04% |
$1,838,276
$222.39 p/Share
|
Dec 24
2020 |
|
NARI
|
Gilde Healthcare Iv U.A. Cooperatieve
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 39,068 Reduced 0.16% |
$3,209,827
$82.16 p/Share
|
Dec 24
2020 |
|
GEF-B
|
Lawrence A. Hilsheimer
EVP and CFO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.77% |
$233,300
$46.66 p/Share
|
Dec 24
2020 |
|
CRVL
|
V Gordon Clemons |
SELL
Open market or private sale
|
Indirect | 1,200 Reduced 0.18% |
$126,012
$105.01 p/Share
|
Dec 24
2020 |
|
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 11,500 Reduced 9.48% |
$576,840
$50.16 p/Share
|
Dec 24
2020 |
|
RGNX
|
Vittal Vasista
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,376 Reduced 2.48% |
$168,800
$50.0 p/Share
|
Dec 24
2020 |